South Africa’s Afrigen makes mRNA COVID vaccine.
“We will only make our clinical trial batch probably in six months from now, (meaning) … fit for humans. And the target is November 2022,”
“We will only make our clinical trial batch probably in six months from now, (meaning) … fit for humans. And the target is November 2022,”
Admissions for malaria are falling, as is the severity of symptoms
Tens of thousands of tonnes of medical waste have been generated in the two years since the coronavirus began spreading globally.
“This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “ Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year.”
BioNTech selects Rwanda, Senegal for potential malaria and tuberculosis mRNA vaccine manufacturing